-
Circle Aug. 12-15, 2004, on the calendar for the Minority Womens Health Summit sponsored by the Office of Public Health and Science, Office on Womens Health. The summit, Women of Color, Taking Action for a Healthier Life: Progress, Partnerships and Possibilities, will build upon the first national conference held in 1997.
-
Over the past decade, 18 states have obtained federal approval to extend eligibility for Medicaid-covered family planning services to individuals who would otherwise not be eligible. The first national evaluation of these efforts found that every one of the programs studied not only met the requirement that they not result in additional costs to the federal government, but actually saved money.
-
What is your approach when it comes to repeat doses of the levonorgestrel-only emergency contraceptive pill (ECP), Plan B (Womens Capital Corp., Washington, DC)? Comments on this question are offered by Contraceptive Technology Update Editorial Advisory Board members.
-
The Today contraceptive sponge awaits the results of a Food and Drug Administration (FDA) review to return to the shelves in the United States. After being approved by the FDA in 1983, the sponge achieved considerable popularity before production was discontinued in 1995. Since then, Allendale (NJ) Pharmaceuticals has purchased rights to the Today sponge and has been working to bring the product back to the United States.
-
Check the following web wites to get teen-friendly information to hare with your adolescent patients...
-
Direct distribution of birth control may be an effective strategy for school-based clinics wishing to remove barriers to contraceptive access, according to research findings from Minnesota public health officials.
-
The decision to move the levonorgestrel emergency contraceptive pill Plan B (Barr Laboratories, Pomona, NY) to over-the-counter status has been delayed by the Food and Drug Administration.
-
Strides are being made when it comes to herpes. New treatments are emerging, and an advanced clinical trial of a potential herpes vaccine now is under way.
-
According to AGI's study, contraceptive coverage improved dramatically between 1993 and 2002 among health plans purchased by employers for their employees.In 2001 and 2002, AGI researchers surveyed insurance companies across the nation, asking whether prescription contraceptives and other comparable drugs, devices, and services were covered in the "typical" managed care plans they wrote for their employers.
-
Add the latest research finding to your counseling on progestin-only injectable and implant contraception: Results from a large U.S. study provide further evidence that these types of birth control do not raise a womans risk of breast cancer.
